Origin and Fate of Erythropoietin in Human Milk
- 1 November 2000
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 48 (5) , 660-667
- https://doi.org/10.1203/00006450-200011000-00018
Abstract
Erythropoietin (Epo) is a normal constituent of human milk, but the origin and fate of this cytokine in milk are not known. Regarding its origin, we hypothesized that cells of the mammary gland secrete Epo into milk actively and, therefore, that concentrations in milk do not correlate with concentrations in serum. Regarding its fate, we hypothesized that Epo concentrations in milk change with time postpartum and that Epo in milk is protected from digestion in the neonatal gastrointestinal tract. To address these issues, we measured Epo concentrations in 103 milk samples (ELISA), 55 of which were paired with serum. Mammary duct epithelial cells were evaluated as a source of Epo by breast tissue immunohistochemistry and by cell culture. Circulating and milk Epo were compared by Western analysis to detect size differences, possibly reflecting differences in processing. Epo stability in simulated conditions of digestion was evaluated. We observed that milk Epo concentrations increase as a function of duration of breast-feeding and have a negative correlation with serum Epo or milk protein concentration. Mammary duct epithelial cells from breast biopsies of lactating women had marked immunoreactivity to Epo, but such activity was minimal to absent in nonlactating breast tissue. Further evidence that mammary duct epithelia produce Epo was obtained by observing Epo mRNA and protein expression in cultured human mammary epithelial cells. The molecular size of Epo in milk and serum is identical. Recombinant Epo added to human milk or commercial infant formulas was relatively stable in conditions that simulate gastric and small intestinal conditions of newborn infants; however, recombinant Epo added to D5W was not protected from digestion. We conclude that Epo concentrations in milk increase as a function of the duration of breast feeding, that Epo is actively secreted into human milk by mammary duct epithelia, and that the Epo within milk is largely protected from digestion.Keywords
This publication has 13 references indexed in Scilit:
- Why Is Erythropoietin Present in Human Milk? Studies of Erythropoietin Receptors on Enterocytes of Human and Rat NeonatesPediatric Research, 1999
- Erythropoietin, given enterally, stimulates erythropoiesis in premature infantsThe Lancet, 1999
- Human Milk as a Potential Enteral Source of ErythropoietinPediatric Research, 1998
- Erythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous SystemPediatric Research, 1998
- Erythropoietin Stimulates Proliferation of Rat-Cultured Gastric Mucosal CellsDigestion, 1996
- The effect of regular maternal exercise on erythropoietin in cord blood and amniotic fluidAmerican Journal of Obstetrics and Gynecology, 1995
- Markers of acute and chronic asphyxia in infants with meconium-stained amniotic fluidAmerican Journal of Obstetrics and Gynecology, 1995
- A method for isolation of cDNA-quality mRNA from immature seeds of a gymnosperm rich in polyphenolicsPlant Molecular Biology, 1993
- Meal-stimulated pepsinogen secretion in premature infantsThe Journal of Pediatrics, 1987
- Understanding Gastric EmptyingJournal of Pediatric Gastroenterology and Nutrition, 1985